Form 8-K · Current report
Illumina, Inc. 8-K, filed Oct 13, 2026
- Filed
- CIK
- 0001110803
- Accession no.
- 0001110803-26-000195
Summary
Illumina, Inc. entered into dealer agreements on October 8, 2026 to establish an unsecured commercial paper program under which it may issue up to $1.0 billion in short-term notes, with no notes outstanding as of the filing. Three dealers will place the notes and a national bank will serve as issuing and paying agent, with proceeds expected to fund general corporate purposes.
Key points
- The program allows up to $1.0 billion in aggregate principal of commercial paper notes outstanding at any time, which may be borrowed, repaid and re-borrowed.
- Note maturities may not exceed 397 days from issuance, and notes will be sold at a discount from par or at par with fixed or floating interest rates.
- Three commercial paper dealers will act as dealers, and a national bank will act as issuing and paying agent.
- Net proceeds are expected to be used for general corporate purposes; the notes are unregistered and sold under exemptions from federal and state securities laws.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 1.01Entry into a Material Definitive Agreement
- 2.03Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
- 9.01Financial Statements and Exhibits
From the filing
Item 1.01. Entry into a Material Definitive Agreement. Entry into Dealer Agreements On October 8, 2026, Illumina, Inc. (the “Company”) entered into definitive documentation to establish an unsecured commercial paper program (the “CP Program”) pursuant to which the Company may issue short-term, unsecured commercial paper notes (the “CP Notes”) pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.